Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Bayer Receives FDA Approval for BETACONNECT - First and Only Electronic Autoinjector in Relapsing-Remitting Multiple Sclerosis (RRMS) Treatment
Inflammation-mediated memory dysfunction and effects of a ketogenic diet in a murine model of multiple sclerosis.
MiR-126: a novel route for natalizumab action?
Lipoatrophy in patients with multiple sclerosis on glatiramer acetate.
The Symptom Inventory Disability-Specific Short Forms for Multiple Sclerosis: Reliability and Factor Structure.
Effects of dalfampridine on multi-dimensional aspects of gait and dexterity in multiple sclerosis among timed walk responders and non-responders.
Behavioral interventions in multiple sclerosis: a biopsychosocial perspective.
Defining high, medium and low impact prognostic factors for developing multiple sclerosis.
New Drug Review 2010: Ustekinumab (Stelara, Centocor Ortho Biotech)
B-57The Temporal Onset of Cognitive Fatigue in Multiple Sclerosis.
Regional Cervical Cord Atrophy and Disability in Multiple Sclerosis: A Voxel-based Analysis.
Withdrawal of fingolimod treatment for relapsing-remitting multiple sclerosis: report of six cases.
CCSVI and MS: no meaning, no fact.
B-07The Cognitive Health Questionnaire: Initial Psychometric Data in a Multisite Multiple Sclerosis Sample.
A second-generation ELISA (STRATIFY JCV™ DxSelect™) for detection of JC virus antibodies in human serum and plasma to support progressive multifocal leukoencephalopathy risk stratification.
Inhibition of Interferon-beta Responses in Multiple Sclerosis Immune Cells Associated With High-Dose Statins.
Cytochrome P450 3A4 is the major enzyme responsible for the metabolism of laquinimod, a novel immunomodulator.
Oral dalfampridine improves standing balance detected at static posturography in multiple sclerosis.
Safety, tolerability, and efficacy of orally administered cannabinoids in MS.
The risk of Bipolar Disorders in Multiple Sclerosis.
Implication of perturbed axoglial apparatus in early pediatric multiple sclerosis.
A new prevalence study of multiple sclerosis in Orkney, Shetland and Aberdeen city.
Progenitor-derived Oligodendrocyte Culture System from Human Fetal Brain.
Autoimmunity: Rubbing salt in the wound.
The microglial sensome revealed by direct RNA sequencing.
Pages
« first
‹ previous
…
126
127
128
129
130
131
132
133
134
…
next ›
last »